Figure 4 | Scientific Reports

Figure 4

From: Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18

Figure 4

MBU-7 and MBU-8 display different drug sensitivity. (a) Percentage of live MBU-7 or MBU-8 cells after 4 days of treatment with indicated concentrations of azacitidine, decitabine or cytarabine. (b) Percentage of live MBU-7 or MBU-8 cells after 4 days of treatment with indicated concentrations of venetoclax. (a,b) Data represent the mean ± SEM of four independent experiments. Statistical analysis was performed using ANOVA. *p-value < 0.01. ns non-significant.

Back to article page